Suppr超能文献

相似文献

1
Habitual intake of dietary flavonoids and risk of Parkinson disease.
Neurology. 2012 Apr 10;78(15):1138-45. doi: 10.1212/WNL.0b013e31824f7fc4. Epub 2012 Apr 4.
2
Intake of Flavonoids and Flavonoid-Rich Foods and Mortality Risk Among Individuals With Parkinson Disease: A Prospective Cohort Study.
Neurology. 2022 Mar 8;98(10):e1064-e1076. doi: 10.1212/WNL.0000000000013275. Epub 2022 Jan 26.
3
Intake of dietary flavonoids and risk of epithelial ovarian cancer.
Am J Clin Nutr. 2014 Nov;100(5):1344-51. doi: 10.3945/ajcn.114.088708. Epub 2014 Aug 20.
5
Dietary flavonoid intake and incidence of erectile dysfunction.
Am J Clin Nutr. 2016 Feb;103(2):534-41. doi: 10.3945/ajcn.115.122010. Epub 2016 Jan 13.
6
Habitual intake of flavonoid subclasses and risk of colorectal cancer in 2 large prospective cohorts.
Am J Clin Nutr. 2016 Jan;103(1):184-91. doi: 10.3945/ajcn.115.117507. Epub 2015 Nov 4.
7
Higher dietary anthocyanin and flavonol intakes are associated with anti-inflammatory effects in a population of US adults.
Am J Clin Nutr. 2015 Jul;102(1):172-81. doi: 10.3945/ajcn.115.108555. Epub 2015 May 27.
8
Dietary flavonoid intake at midlife and healthy aging in women.
Am J Clin Nutr. 2014 Dec;100(6):1489-97. doi: 10.3945/ajcn.114.085605. Epub 2014 Oct 29.
9
Dietary flavonoid intake and risk of incident depression in midlife and older women.
Am J Clin Nutr. 2016 Sep;104(3):704-14. doi: 10.3945/ajcn.115.124545. Epub 2016 Jul 13.
10
Estimation of daily intake of flavonoids and major food sources in middle-aged Australian men and women.
Nutr Res. 2019 Jan;61:64-81. doi: 10.1016/j.nutres.2018.10.006. Epub 2018 Oct 28.

引用本文的文献

5
Pelargonium graveolens Attenuates Rotenone-Induced Parkinson's Disease in a Rat Model: Role of MAO-B Inhibition and In Silico Study.
Mol Neurobiol. 2025 Jun;62(6):7664-7681. doi: 10.1007/s12035-025-04727-6. Epub 2025 Feb 8.
6
Identifying Individuals in the Prodromal Phase of Parkinson's Disease: A Prospective Cohort Study.
Ann Neurol. 2025 Apr;97(4):720-729. doi: 10.1002/ana.27166. Epub 2024 Dec 19.
8
Microbiome-based therapeutics for Parkinson's disease.
Neurotherapeutics. 2024 Oct;21(6):e00462. doi: 10.1016/j.neurot.2024.e00462. Epub 2024 Oct 11.
9
Therapeutic effect of targeted antioxidant natural products.
Discov Nano. 2024 Sep 10;19(1):144. doi: 10.1186/s11671-024-04100-x.
10
The Effects of Fisetin and Curcumin on Oxidative Damage Caused by Transition Metals in Neurodegenerative Diseases.
Mol Neurobiol. 2025 Jan;62(1):1225-1246. doi: 10.1007/s12035-024-04321-2. Epub 2024 Jul 6.

本文引用的文献

1
Antioxidant and drug detoxification potentials of Hibiscus sabdariffa anthocyanin extract.
Drug Chem Toxicol. 2011 Apr;34(2):109-15. doi: 10.3109/01480545.2010.536767.
3
Habitual intake of flavonoid subclasses and incident hypertension in adults.
Am J Clin Nutr. 2011 Feb;93(2):338-47. doi: 10.3945/ajcn.110.006783. Epub 2010 Nov 24.
4
Plasma urate and Parkinson's disease in women.
Am J Epidemiol. 2010 Sep 15;172(6):666-70. doi: 10.1093/aje/kwq195. Epub 2010 Aug 2.
5
Oral pelargonidin exerts dose-dependent neuroprotection in 6-hydroxydopamine rat model of hemi-parkinsonism.
Brain Res Bull. 2010 Jul 30;82(5-6):279-83. doi: 10.1016/j.brainresbull.2010.06.004. Epub 2010 Jun 15.
6
Xenobiotic metabolism and berry flavonoid transport across the blood-brain barrier.
J Agric Food Chem. 2010 Apr 14;58(7):3950-6. doi: 10.1021/jf903529m.
8
Berry anthocyanins and anthocyanidins exhibit distinct affinities for the efflux transporters BCRP and MDR1.
Br J Pharmacol. 2009 Dec;158(8):1942-50. doi: 10.1111/j.1476-5381.2009.00495.x.
9
Antidepressant-like effect of low molecular proanthocyanidin in mice: involvement of monoaminergic system.
Pharmacol Biochem Behav. 2010 Jan;94(3):447-53. doi: 10.1016/j.pbb.2009.10.007. Epub 2009 Oct 23.
10
Family history of melanoma and Parkinson disease risk.
Neurology. 2009 Oct 20;73(16):1286-91. doi: 10.1212/WNL.0b013e3181bd13a1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验